Pablo Lubroth MPhil

Board Observer

Pablo leads the biotechnology practice at Hummingbird. Previously, Pablo was an Investment Manager at UKI2S, investing in early stage cell and gene therapy companies, and worked as a Corporate Development Associate at the gene editing company Horizon Discovery.

He holds degrees in Neuropharmacology and Biochemical Engineering from University College London and an MPhil in Bioscience Enterprise from the University of Cambridge.